Consejo Superior de Investigaciones Científicas posted this:Modulating compounds of KChIP2 and its use for the treatment of cardiovascularppaatthhoollooggiieess CSIC and UAM have developed compounds that positively modulate protein-protein interactions that involve KChIP2 protein. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement An offer for Patent Licensing
Technology Transfer OfficeView Profile
Yissum - Research Development Company of the Hebrew University posted this:Naturally Occurring Compounds for Treating Pathogenic Factors Common to Cystic FibrosisCannabis project Derivatives of cannabinoids have an antimicrobial and anti biofilm effect on pseudomonas and candida which are major ethological pathogenic factors in CF Project ID : 6-2019-6720
Consejo Superior de Investigaciones Científicas posted this:Compounds for the treatment and prevention of immune-mediated inflammatory diseasesCSIC and the University of Athens have found that secoiridoids, such as oleacein and oleocanthal, are useful to prevent or treat illnesses that results in immune-mediated gastrointestinal alterations. A company dealing with pharmaceutical or nutraceutical compositions is sought for licensing agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones Científicas posted this:Compounds for the treatment of optic neuritisCSIC and the University of Athens have found that secoiridoids, such as oleacein and oleocanthal, are useful to prevent or treat neuropathies that conduct to optic nerve injury, such as optic neuritis. A company dealing with pharmaceutical or nutraceutical compositions for ophtalmic applications is sought for licensing agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones Científicas posted this:Regulatory compounds of synaptic transmission for the treatment of neurological diseasesThe CSIC and IRYCIS (Ramón y Cajal Institute for Health Research) have developed a group of compounds. These compounds have the ability to regulate the number of synapses that are formed between neurons, as well as the probability that neurotransmitters are released from these, because they have the capability of modulate the interactions that take place between the regulatory proteins NCS-1 and Ric8a that regulate these two independent processes. Due to these neuromodulatory properties, these compounds are useful for the treatment of neurological diseases as Alzheimer's disease, Huntington or Parkinson's diseases among others. Industrial partners from the ophthalmic or pharmaceutical industry are being sought to collaborate through a patent license agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones Científicas posted this:Antibiotics to treat diseases caused by HelicobacterCSIC, the University of Zaragoza, Institute Pasteur, IISA and ARAID have developed chemical derivatives that act selectively against the bacterium Helicobacter pylori, managing to reduce the bacterial load and even eradicate gastric infections caused by it. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing
Centre Technology Transfer CITTRU posted this:New UV-blocker for sunscreen with high bactericidal activityThe offered material is based on ZnO nanoparticles, modified with biocompatible polymer – chitosan. The material is characterized by high absorption properties of the sun’s ultraviolet (UV) radiation. Also, high antibacterial activity against resistant bacterial strains and the absence of cytotoxic activity against human skin cells of the material were confirmed. Application: cosmetics, sunscreen, skincare, medical applications
Radoslaw Rudz posted this:
Licensing Manager at Centre Technology Transfer CITTRU
UACOOPERA posted this:
Technology Transfer Office at uacoopera
UACOOPERA posted this:
Technology Transfer Office at uacoopera
Aia Malik posted this:
Commercial Development Manager at Lucideon
Universidad de Alcalá-OTRI posted this:Double port injector to corneal transplant DMEKThe Reseacrh group in Cell biology of solid tumors and tisular regeneration from Alcala University and the Research group in Cellular Engineering from University from Hospital La Paz, have developed a new injector designed to reduce endotellial damage during the corneal endothelial graft implantation in eye´s anterior chamber. The group is looking for cooperation or commercial agreement with companies manufacturers of sanitary products and medical devices, ophthalmological clinics and hospitals.
Universidad de Alicante posted this:Novel self-expanding polyurethane foams intended for inert filling of pleural and other human cavities.The Adhesion and Adhesives Laboratory of the University of Alicante has developed a new polymeric foaming material for in-situ filling and sealing of internal irregular different shaped human cavities, intended for patients suffering chronic pleural cavities and in-field injuries caused by bullets or accidental event leaving open blood vessels. The new foam is composed of two separate liquid components that can be mixed in a two-body syringe in such a way that the foaming time can be modulated for allowing the foam formation at the end of the syringe needle. The new polymeric foam can self-expanded and self-modelated for avoiding complications in open internal cavities caused by infections, blooding, fistulae, dyspnea or sepsis. The new foam is easily applicable, safe for biological tissues, and its use avoid the use of the current aggressive treatments in pleural cavities. It is looking for companies interested in acquiring this technology for its commercial exploitation.
Institute of Chemical Research of Catalonia posted this:Optical Quantification of enzymatic activity: a non-invasive diagnosis toolThe platform allows for accurate measurement of the enzymatic activity thanks to the presence of an optical signal that remains unchanged during digestion and serves as a ruler to which modifications of another signal, affected by enzymatic activity, is compared. The platform can be used in small devices, at point of care and in non-invasive diagnostic procedures. The platform is also highly versatile as a simple modification of the particle will allow using it in totally different diagnostic applications.
Universidad de Alcalá-OTRI posted this:Double mesh prosthesis that corrects defects in the abdominal wall and prevents adhesion formation at the peritoneal interfaceA research group from the Surgery Department of Alcala University has designed an implantable prosthesis made of two meshes joined together, for abdominal surgery uses. This prosthesis prevents the erosion of the viscera by promoting mesothelial deposition. Both meshes induce fibroblast proliferation and collagen deposition achieving the definitive repair of the defect at the expense of connective tissue. This research group is looking for manufacturing and license agreements.